These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 35402423)
1. Effective Diagnosis of Prostate Cancer Based on mRNAs From Urinary Exosomes. Gan J; Zeng X; Wang X; Wu Y; Lei P; Wang Z; Yang C; Hu Z Front Med (Lausanne); 2022; 9():736110. PubMed ID: 35402423 [TBL] [Abstract][Full Text] [Related]
2. A molecular signature of PCA3 and ERG exosomal RNA from non-DRE urine is predictive of initial prostate biopsy result. Donovan MJ; Noerholm M; Bentink S; Belzer S; Skog J; O'Neill V; Cochran JS; Brown GA Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):370-5. PubMed ID: 26345389 [TBL] [Abstract][Full Text] [Related]
3. Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer. Leyten GH; Hessels D; Jannink SA; Smit FP; de Jong H; Cornel EB; de Reijke TM; Vergunst H; Kil P; Knipscheer BC; van Oort IM; Mulders PF; Hulsbergen-van de Kaa CA; Schalken JA Eur Urol; 2014 Mar; 65(3):534-42. PubMed ID: 23201468 [TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of urinary prostate cancer antigen-3 (PCA3) and TMPRSS2-ERG score changes when starting androgen-deprivation therapy with triptorelin 6-month formulation in patients with locally advanced and metastatic prostate cancer. Martínez-Piñeiro L; Schalken JA; Cabri P; Maisonobe P; de la Taille A; BJU Int; 2014 Oct; 114(4):608-16. PubMed ID: 24806330 [TBL] [Abstract][Full Text] [Related]
6. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. Tomlins SA; Day JR; Lonigro RJ; Hovelson DH; Siddiqui J; Kunju LP; Dunn RL; Meyer S; Hodge P; Groskopf J; Wei JT; Chinnaiyan AM Eur Urol; 2016 Jul; 70(1):45-53. PubMed ID: 25985884 [TBL] [Abstract][Full Text] [Related]
7. Urine-derived exosomal PSMA is a promising diagnostic biomarker for the detection of prostate cancer on initial biopsy. Wang CB; Chen SH; Zhao L; Jin X; Chen X; Ji J; Mo ZN; Wang FB Clin Transl Oncol; 2023 Mar; 25(3):758-767. PubMed ID: 36266386 [TBL] [Abstract][Full Text] [Related]
8. A Novel Urine Exosomal lncRNA Assay to Improve the Detection of Prostate Cancer at Initial Biopsy: A Retrospective Multicenter Diagnostic Feasibility Study. Li Y; Ji J; Lyu J; Jin X; He X; Mo S; Xu H; He J; Cao Z; Chen X; Xu Y; Wang L; Wang F Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439239 [TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of Peripheral Blood PCA3 Gene Expression in Early Diagnosis of Prostate Cancer. Chunhua L; Zhao H; Zhao H; Lu Y; Wu J; Gao Z; Li G; Zhang Y; Wang K Transl Oncol; 2018 Jun; 11(3):628-632. PubMed ID: 29574327 [TBL] [Abstract][Full Text] [Related]
10. Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer. Salami SS; Schmidt F; Laxman B; Regan MM; Rickman DS; Scherr D; Bueti G; Siddiqui J; Tomlins SA; Wei JT; Chinnaiyan AM; Rubin MA; Sanda MG Urol Oncol; 2013 Jul; 31(5):566-71. PubMed ID: 21600800 [TBL] [Abstract][Full Text] [Related]
11. Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients. Li Z; Ma YY; Wang J; Zeng XF; Li R; Kang W; Hao XK Onco Targets Ther; 2016; 9():139-48. PubMed ID: 26770063 [TBL] [Abstract][Full Text] [Related]
12. Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer. Cornu JN; Cancel-Tassin G; Egrot C; Gaffory C; Haab F; Cussenot O Prostate; 2013 Feb; 73(3):242-9. PubMed ID: 22821767 [TBL] [Abstract][Full Text] [Related]
13. PCA3 and TMPRSS2-ERG gene fusions as diagnostic biomarkers for prostate cancer. Yang Z; Yu L; Wang Z Chin J Cancer Res; 2016 Feb; 28(1):65-71. PubMed ID: 27041928 [TBL] [Abstract][Full Text] [Related]
14. Identification of Urinary Exosomal miRNAs for the Non-Invasive Diagnosis of Prostate Cancer. Li Z; Li LX; Diao YJ; Wang J; Ye Y; Hao XK Cancer Manag Res; 2021; 13():25-35. PubMed ID: 33442291 [TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomes. Hendriks RJ; Dijkstra S; Jannink SA; Steffens MG; van Oort IM; Mulders PF; Schalken JA Clin Chem Lab Med; 2016 Mar; 54(3):483-92. PubMed ID: 26630694 [TBL] [Abstract][Full Text] [Related]
16. Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer. Liu P; Wang W; Wang F; Fan J; Guo J; Wu T; Lu D; Zhou Q; Liu Z; Wang Y; Shang Z; Chan FL; Yang W; Li X; Zhao SC; Zheng Q; Wang F; Wu D J Transl Med; 2023 Jan; 21(1):40. PubMed ID: 36681849 [TBL] [Abstract][Full Text] [Related]
17. Prostate-based biofluids for the detection of prostate cancer: A comparative study of the diagnostic performance of cell-sourced RNA biomarkers. Roberts MJ; Richards RS; Chow CW; Doi SA; Schirra HJ; Buck M; Samaratunga H; Perry-Keene J; Payton D; Yaxley J; Lavin MF; Gardiner RA Prostate Int; 2016 Sep; 4(3):97-102. PubMed ID: 27689066 [TBL] [Abstract][Full Text] [Related]
18. Comparative assessment of urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion with the serum [-2]proprostate-specific antigen-based prostate health index for detection of prostate cancer. Stephan C; Jung K; Semjonow A; Schulze-Forster K; Cammann H; Hu X; Meyer HA; Bögemann M; Miller K; Friedersdorff F Clin Chem; 2013 Jan; 59(1):280-8. PubMed ID: 23213079 [TBL] [Abstract][Full Text] [Related]
19. Exosomal Prostate-Specific Membrane Antigen (PSMA) and Caveolin-1 as Potential Biomarkers of Prostate Cancer-Evidence from Serbian Population. Matijašević Joković S; Korać A; Kovačević S; Djordjević A; Filipović L; Dobrijević Z; Brkušanin M; Savić-Pavićević D; Vuković I; Popović M; Brajušković G Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542507 [TBL] [Abstract][Full Text] [Related]
20. Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions. Hendriks RJ; van Oort IM; Schalken JA Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):12-19. PubMed ID: 27922627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]